-
Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation
23 Sep 2025 03:47 GMT
… advanced squamous non-small cell lung cancer (sq-NSCLC), has been selected … ) of cadonilimab in combination with oxaliplatin and capecitabine as first-line … advanced squamous non-small cell lung cancer (HARMONi-6)
Speakers: Professor Shun …
-
Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
19 Jul 2025 11:24 GMT
… : non-small cell lung cancer, postoperative adjuvant chemotherapy, … resected non-small cell lung cancer. Lung Cancer. 2008;62(1 … -based concurrent chemoradiotherapy. Lung Cancer. 2010;68(2 … colorectal cancer patients receiving oxaliplatin and fluorouracil (5- …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… agents, including cyclophosphamide, oxaliplatin, epirubicin, and … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer … small cell lung cancer patients. Lung Cancer. 2011;72 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02 Jun 2025 16:00 GMT
… and Non-Small Cell Lung Cancer
Two presentations at the … results at ASCO. In lung cancer, patient recruitment is progressing … metastatic non-small cell lung cancer and secondary resistance to … acid, fluorouracil, irinotecan and oxaliplatin
3 Trends in the …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… and MPR.
About Lung Cancer
Lung cancer is the leading cause … treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.
OPDIVO® … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript
18 Sep 2025 12:47 GMT
… gemcitabine and oxaliplatin versus gemcitabine and oxaliplatin in relapsed … III clinical trial in lung cancer by our partner, AstraZeneca … unresectable non-small cell lung cancer and in the neoadjuvant … III non-small cell lung cancer who have not progressed …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
About
© 1995-2025